Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia

Curtis Chan; Stefanie Vaccher; Doug Fraser; Andrew E Grulich; Martin Holt; Iryna Zablotska-Manos; Garrett P Prestage; Benjamin R Bavinton

doi:10.1007/s10461-021-03344-3

Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia

AIDS Behav. 2022 Jan;26(1):88-95. doi: 10.1007/s10461-021-03344-3. Epub 2021 Jun 17.

Authors

Curtis Chan¹, Stefanie Vaccher², Doug Fraser², Andrew E Grulich², Martin Holt³, Iryna Zablotska-Manos⁴, Garrett P Prestage², Benjamin R Bavinton²

Affiliations

¹ The Kirby Institute, UNSW Sydney, Sydney, NSW, 2052, Australia. cchan@kirby.unsw.edu.au.
² The Kirby Institute, UNSW Sydney, Sydney, NSW, 2052, Australia.
³ The Centre for Social Research in Health, UNSW Sydney, Sydney, NSW, Australia.
⁴ Sydney Medical School - Westmead and Western Sydney Sexual Health Centre, University of Sydney, Sydney, Australia.

PMID: 34142274
DOI: 10.1007/s10461-021-03344-3

Abstract

Alternatives to daily dosing of HIV pre-exposure prophylaxis (PrEP) are continuing to emerge. From October 2019 to March 2020, we conducted an online survey of PrEP-experienced gay and bisexual men in Australia about interest in and preference for four different PrEP modalities: daily dosing, event-driven dosing, long-acting injectable (LAI)-PrEP and subdermal PrEP implants. Using data from 1477 participants, we measured interest and preference of different modalities using multivariate logistic regression. High proportions of participants were interested in LAI-PrEP (59.7%), daily PrEP (52.0%), PrEP implants (45.3%) and event-driven PrEP (42.8%). LAI-PrEP was the most frequently selected preference (30.5%), followed by PrEP implants (26.3%), daily PrEP (21.4%) and event-driven PrEP (21.2%). Higher interest and preference for non-daily PrEP modalities were associated with being concerned about side effects and perceived difficulties with daily adherence. As novel modalities emerge, attitudes to them should be considered in public health messaging to facilitate informed decision-making.

Keywords: HIV; Injectable; Men who have sex with men; On-demand; Pre-exposure prophylaxis.

MeSH terms

Anti-HIV Agents* / therapeutic use
HIV Infections* / drug therapy
HIV Infections* / prevention & control
Homosexuality, Male
Humans
Male
Pre-Exposure Prophylaxis*
Sexual and Gender Minorities*

Substances

Anti-HIV Agents